Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Alkermes (ALKS) Receivables - Other (2016 - 2025)

Alkermes has reported Receivables - Other over the past 11 years, most recently at $717000.0 for Q3 2025.

Quarterly Receivables - Other fell 75.85% to $717000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $717000.0 through Sep 2025, down 75.85% year-over-year, with the annual reading at $5.0 million for FY2024, 95.16% down from the prior year.
Receivables - Other was $717000.0 for Q3 2025 at Alkermes, down from $1.4 million in the prior quarter.
Over five years, Receivables - Other peaked at $20.2 million in Q1 2022 and troughed at $706000.0 in Q4 2023.
The 5-year median for Receivables - Other is $6.7 million (2023), against an average of $7.5 million.
Year-over-year, Receivables - Other tumbled 92.09% in 2023 and then skyrocketed 606.8% in 2024.
A 5-year view of Receivables - Other shows it stood at $13.4 million in 2021, then crashed by 33.18% to $8.9 million in 2022, then tumbled by 92.09% to $706000.0 in 2023, then skyrocketed by 606.8% to $5.0 million in 2024, then crashed by 85.63% to $717000.0 in 2025.
Per Business Quant, the three most recent readings for ALKS's Receivables - Other are $717000.0 (Q3 2025), $1.4 million (Q2 2025), and $3.0 million (Q1 2025).